Custom recombinant antibody production involves the generation of antibodies using recombinant DNA technology. This process typically begins with the identification of antibody-encoding genes from immunised animals or human donors. These genes are then cloned into expression vectors and transfected into host cells, such as mammalian cells or bacteria, to produce recombinant antibodies.